{"ticker": {"uuid": "67db6d76-43e1-4ebc-8ca2-d58d3de0c63b", "symbol": "ASMB", "name": "Assembly Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Enterprise value to EBIT forward of Assembly Biosciences, Inc. \u2013 NASDAQ:ASMB", "summary": "The article provides a financial overview of Assembly Biosciences, Inc. (NASDAQ: ASMB), focusing on its enterprise value to EBIT forward. It primarily presents the title and basic identification of the company within a financial data platform. The content primarily consists of na", "url": "https://www.tradingview.com/symbols/NASDAQ-ASMB/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-14T22:42:31", "published_display": "14 Jul 2026 22:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Avoiding Lag: Real-Time Signals in (ASMB) Movement", "summary": "This article provides an AI-generated analysis of Assembly Biosciences Inc. (NASDAQ: ASMB), noting a near-term neutral sentiment amidst mid and long-term strength. It highlights a significant 65.7:1 risk-reward short setup and outlines three institutional trading strategies: a lo", "url": "https://news.stocktradersdaily.com/news_release/10/Avoiding_Lag:_Real-Time_Signals_in_ASMB_Movement_071126061602_1783808162.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-11T18:40:18", "published_display": "11 Jul 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Assembly Biosciences, Inc. \u2013 HAM:V7B", "summary": "This article focuses on the enterprise value to EBIT forward ratio for Assembly Biosciences, Inc. (HAM:V7B) on the Hamburg Stock Exchange. It appears to be a financial data page from TradingView, providing an overview of the company's financials without offering specific numerica", "url": "https://www.tradingview.com/symbols/HAM-V7B/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-10T05:09:47", "published_display": "10 Jul 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Assembly Biosciences, Inc. \u2013 FWB:V7B", "summary": "This article displays information regarding the price to earnings forward of Assembly Biosciences, Inc. (FWB:V7B) on the Frankfurt Stock Exchange. It notes that the market is currently closed with no trades. The article is part of TradingView's financial data offerings.", "url": "https://www.tradingview.com/symbols/FWB-V7B/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-09T18:42:16", "published_display": "09 Jul 2026 18:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Assembly Biosciences, Inc. \u2013 NASDAQ:ASMB", "summary": "This article provides a brief snapshot of the Enterprise Value to Revenue (Forward) for Assembly Biosciences, Inc. (NASDAQ: ASMB) as presented on TradingView. It highlights key financial metrics and navigational elements related to the company's profile on the platform. The conte", "url": "https://www.tradingview.com/symbols/NASDAQ-ASMB/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T11:10:14", "published_display": "08 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) Holds Steady Near Resistance Zone - Overbought Signal Alerts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQOUJDMTdZNTI0amVJSUlMZU1WVXdiNjlZM19ZVTlHOVc5UzNnN3RlRmdUcUhlSDhsZExmNUo4eVp6T0pxRGZ3S3U5Sll6d2ZZZXZla19hVHYxdnZ6azZCOF9yRU8zZnJFOHRDaXNFemo1cl83SjJZbUR6bG5YcVNYU3hveDBDXzE4b3hiekVILXk3OEt5OTJoSDBtTFVUcVhzMXVr?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-07T18:36:07+00:00", "published_display": "07 Jul 2026 18:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Assembly Biosciences, Inc. \u2013 NASDAQ:ASMB", "summary": "This article focuses on the enterprise value to EBITDA forward metric for Assembly Biosciences, Inc. (NASDAQ: ASMB). It indicates that the company's financial data is available for review, likely on the TradingView platform. The content primarily serves as a placeholder for detai", "url": "https://www.tradingview.com/symbols/NASDAQ-ASMB/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T06:39:31", "published_display": "07 Jul 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Assembly Biosciences, Inc. \u2013 NASDAQ:ASMB", "summary": "This article provides a financial snapshot for Assembly Biosciences, Inc. (NASDAQ: ASMB), focusing on its price to book forward metric. It appears to be a stub or an incomplete data entry from TradingView, lacking detailed financial figures but highlighting the company within the", "url": "https://www.tradingview.com/symbols/NASDAQ-ASMB/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T21:11:32", "published_display": "05 Jul 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASMB - Assembly Biosciences Inc Options", "summary": "This article provides a detailed financial overview of Assembly Biosciences Inc. (ASMB), including its current stock performance, key financial metrics, analyst ratings, and insider transaction data. It highlights the company's valuation, profitability, growth rates, and market i", "url": "https://finviz.com/stock?t=ASMB&ta=1&p=m&ty=oc&b=2&ov=chain_strike&s=35", "source_name": "Finviz", "published_at": "2026-07-02T22:09:28", "published_display": "02 Jul 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Discipline and Rules-Based Execution in ASMB Response", "summary": "This article provides an in-depth analysis of Assembly Biosciences Inc. (NASDAQ: ASMB), highlighting strong sentiment across all horizons and identifying a mid-channel oscillation pattern. It presents three AI-generated institutional trading strategies\u2014Position Trading, Momentum ", "url": "https://news.stocktradersdaily.com/news_release/12/Discipline_and_Rules-Based_Execution_in_ASMB_Response_063026050801_1782853681.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-30T17:08:00", "published_display": "30 Jun 2026 17:08", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 2500 Index", "summary": "Assembly Biosciences, Inc. (NasdaqGS: ASMB), a biotechnology company focused on developing therapies for serious viral diseases, has been added to the Russell 2500 Index. This inclusion is one of several recent adjustments for the company across various Russell indices, including", "url": "https://www.marketscreener.com/news/assembly-biosciences-inc-nasdaqgs-asmb-added-to-russell-2500-index-ce7f5fdfd188f523", "source_name": "marketscreener.com", "published_at": "2026-06-29T13:11:46", "published_display": "29 Jun 2026 13:11", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 3000E Value Benchmark", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNNUw5UkIzSjVhczhpajVqb1NRV0FqMk9LemRzRGpJbnB2ckMtUjltV1ItTDBLdnFDeG93S2Zub2tfQW84cWN4WkNncGVGMG05eXhCRFZSZDZCbGkxOWZraXhYNFlvZDdzVEU2VGxOSFY3RnhEbjdTQTFVSmN6VW8xaU1yOXlNTTk1Mm1zR2tLc1lBYWtuZ2RVY2JRMkZuRm01d0hPOHhVS2VMQzhJdFpiSExaOGxReDJZQ2ZNdXNwNmFhanY1eTZScVR3?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences, Inc. Actuals & Estimates (NASDAQ:ASMB)", "summary": "This article provides an overview of Assembly Biosciences, Inc. (NASDAQ: ASMB) stock, including its current price, market capitalization, and historical performance. It details analyst forecasts, past earnings reports, and upcoming financial dates, such as the next earnings relea", "url": "https://www.tradingview.com/symbols/NASDAQ-ASMB/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T05:40:22", "published_display": "26 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASMB Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Assembly Biosciences, Inc. (ASMB) stock, including analyst price targets, historical performance data, and financial metrics. Four analysts have provided 1-year price forecasts, with estimates ranging from $43.00 to $62.00. The company's stock", "url": "https://www.tradingview.com/symbols/NASDAQ-ASMB/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T20:09:46", "published_display": "25 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Inc (ASMB) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Assembly Biosciences Inc (ASMB), detailing its current price momentum score, support and resistance levels. It includes a review of various technical indicators like MACD, RSI, and moving averages, offering \"Sell,\" \"Neutral,\" or \"Buy\"", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-asmb/technical", "source_name": "TradingKey", "published_at": "2026-06-24T18:40:22", "published_display": "24 Jun 2026 18:40", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (Nasdaq:ASMB) - Stock Analysis", "summary": "This report provides a comprehensive stock analysis of Assembly Biosciences (ASMB), detailing its financial performance, future growth prospects, past performance, and risk factors. It highlights that ASMB is trading significantly below its estimated fair value with promising ear", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-asmb/assembly-biosciences", "source_name": "Simply Wall Street", "published_at": "2026-06-23T07:09:11", "published_display": "23 Jun 2026 07:09", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Inc (ASMB) Institutional Confidence", "summary": "This article analyzes the institutional confidence in Assembly Biosciences Inc (ASMB), noting its current score of 5.00 within the Biotechnology & Medical Research industry. Institutional shareholding has increased significantly by 171.06% quarter-over-quarter, now standing at 58", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-asmb/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T16:10:18", "published_display": "18 Jun 2026 16:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) PFO sells 29 shares to cover RSU taxes", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPS2R5UGdWSmxQbjllaGtsREdHb2Qwa0ZWTUVrNjVqUjNicmxjbC1FX3U3M0RGTmVTWTVmY3FhcHN1cGs1WEJOMjJLZzBYUjdQV25NOC1fWFBKd3lla0IzN09pWFpnREpTMDRzM2o3a2dKQ3lORnVZRjVGZ0Fhcl9MSDZnc2pIbUFtenJDeTBZT0laWTZoMTE3R1c1bndQLV81dnc3YURMZlNIdjhwYjVFWVlTcENmMU04c3c?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Inc (ASMB) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Assembly Biosciences Inc (ASMB), detailing its current earnings forecast score, average price target, and analyst ratings. It highlights that the company ranks 16th in the Biotechnology & Medical Research industry with a strong buy c", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-asmb/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T04:41:07", "published_display": "18 Jun 2026 04:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Inc (ASMB) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Assembly Biosciences Inc (ASMB), listing its major shareholders and their proportions, including Gilead Sciences Inc, Farallon Capital Management, and RA Capital Management. It also breaks down shareholder types such as hedge fund", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-asmb/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T21:09:51", "published_display": "17 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Inc (ASMB) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Assembly Biosciences Inc (ASMB) focusing on its dividend and stock split history. It indicates that the company has not distributed dividends in the past five years and lists several stock merger events that occurred on February 8, 2024, with ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-asmb/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T21:09:51", "published_display": "17 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mizuho Raises Price Target on Assembly Biosciences to $45 From $40, Keeps Outperform Rating", "summary": "Mizuho has increased its price target for Assembly Biosciences (ASMB) to $45 from $40, while maintaining an \"Outperform\" rating on the stock. This adjustment comes despite a report within the same article about Unity Software's Q4 earnings, which showed higher-than-expected reven", "url": "https://www.moomoo.com/news/post/71532495/mizuho-raises-price-target-on-assembly-biosciences-to-45-from?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-06-16T03:09:51", "published_display": "16 Jun 2026 03:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead", "summary": "Assembly Biosciences highlighted its antiviral and liver disease development strategy, discussing upcoming decisions for its HSV-2 program with Gilead, the expansion of its hepatitis delta candidate into cholestatic liver diseases, and expected clinical data readouts. The company", "url": "https://www.theglobeandmail.com/investing/markets/stocks/ASMB-Q/pressreleases/2383505/assembly-biosciences-teases-gilead-hsv-2-decision-liver-disease-data-ahead/", "source_name": "The Globe and Mail", "published_at": "2026-06-09T13:09:41", "published_display": "09 Jun 2026 13:09", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences eyes Gilead HSV plan as ABI-6250 liver pipeline expands", "summary": "This article mentions Assembly Biosciences' interest in Gilead's HSV plan and the expansion of its ABI-6250 liver pipeline. No further details are provided in the given content.", "url": "https://www.msn.com/en-us/health/other/assembly-biosciences-eyes-gilead-hsv-plan-as-abi-6250-liver-pipeline-expands/ar-AA24WCUt?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-06-08T21:39:23", "published_display": "08 Jun 2026 21:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(ASMB) Movement Within Algorithmic Entry Frameworks", "summary": "This article from Stock Traders Daily analyzes Assembly Biosciences (ASMB) using AI models, identifying weak near- and mid-term sentiment but a strong long-term outlook. It provides specific algorithmic trading strategies\u2014Long Position, Momentum Breakout, and Risk Hedging Short\u2014a", "url": "https://news.stocktradersdaily.com/news_release/16/ASMB_Movement_Within_Algorithmic_Entry_Frameworks_060826024802_1780944482.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-08T14:48:00", "published_display": "08 Jun 2026 14:48", "sentiment": "negative", "sentiment_pct": 38, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) CEO receives 50,750 RSUs in equity grant", "summary": "Assembly Biosciences (ASMB) CEO and President Jason A. Okazaki received a grant of 50,750 Restricted Stock Units (RSUs) at no cash cost. This grant, approved on March 29, 2026, became issuable after stockholders approved an amendment to the company's 2018 Stock Incentive Plan on ", "url": "https://www.stocktitan.net/sec-filings/ASMB/form-4-assembly-biosciences-inc-insider-trading-activity-566a778a94de.html", "source_name": "Stock Titan", "published_at": "2026-06-06T12:10:46", "published_display": "06 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (NASDAQ: ASMB) awards 8,000 stock options to director McHutchison", "summary": "Assembly Biosciences (NASDAQ: ASMB) has granted 8,000 stock options to its director, John G. McHutchison. These options have an exercise price of $24.11 per share and are set to expire on June 4, 2036. The vesting of these options is contingent on continuous service and will occu", "url": "https://www.stocktitan.net/sec-filings/ASMB/form-4-assembly-biosciences-inc-insider-trading-activity-3f096425de2f.html", "source_name": "Stock Titan", "published_at": "2026-06-06T10:40:20", "published_display": "06 Jun 2026 10:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) CSO granted 14,000 RSUs tied to plan amendment", "summary": "Assembly Biosciences' Chief Scientific Officer, William E. Delaney IV, was granted 14,000 Restricted Stock Units (RSUs), representing 35% of his annual equity award. This grant, made at no cash cost, was contingent on stockholder approval of an amendment to the company's 2018 Sto", "url": "https://www.stocktitan.net/sec-filings/ASMB/form-4-assembly-biosciences-inc-insider-trading-activity-fb393ad3c64a.html", "source_name": "Stock Titan", "published_at": "2026-06-06T00:09:52", "published_display": "06 Jun 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (NASDAQ: ASMB) director receives 8,000 stock options grant", "summary": "Assembly Biosciences director Lisa Johnson-Pratt was granted 8,000 stock options with an exercise price of $24.11 per share, expiring on June 4, 2036. The options vest upon the earlier of June 4, 2027, or the company's 2027 annual stockholder meeting, assuming continuous service.", "url": "https://www.stocktitan.net/sec-filings/ASMB/form-4-assembly-biosciences-inc-insider-trading-activity-7bc09e80a5db.html", "source_name": "Stock Titan", "published_at": "2026-06-05T23:08:49", "published_display": "05 Jun 2026 23:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at Assembly Biosciences (ASMB) receives grant of 8,000 stock options", "summary": "Michael Houghton, a director at Assembly Biosciences (ASMB), has received a grant of 8,000 stock options. These options have an exercise price of $24.11 per share, expire on June 4, 2036, and will vest on the earlier of June 4, 2027, or the company's 2027 annual meeting of stockh", "url": "https://www.stocktitan.net/sec-filings/ASMB/form-4-assembly-biosciences-inc-insider-trading-activity-07d16cbac4d6.html", "source_name": "Stock Titan", "published_at": "2026-06-05T22:40:44", "published_display": "05 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) director receives grant of 8,000 stock options", "summary": "Assembly Biosciences (ASMB) director Susan Mahony was granted 8,000 stock options with an exercise price of $24.11 per share, expiring on June 4, 2036. The options will vest upon the earlier of June 4, 2027, or the company's 2027 annual meeting of stockholders, assuming continuou", "url": "https://www.stocktitan.net/sec-filings/ASMB/form-4-assembly-biosciences-inc-insider-trading-activity-712d89588682.html", "source_name": "Stock Titan", "published_at": "2026-06-05T22:40:44", "published_display": "05 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) CMO awarded 14,000 restricted stock units", "summary": "Assembly Biosciences' Chief Manufacturing Officer, Nicole S. White, was granted 14,000 restricted stock units (RSUs) as part of her annual equity compensation. This grant, approved on March 29, 2026, became issuable after stockholders approved an amendment to the company\u2019s 2018 S", "url": "https://www.stocktitan.net/sec-filings/ASMB/form-4-assembly-biosciences-inc-insider-trading-activity-a0a69b1f46d7.html", "source_name": "Stock Titan", "published_at": "2026-06-05T21:11:02", "published_display": "05 Jun 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Announces Upcoming Investor Conference Presentations", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/assembly-biosciences-announces-upcoming-investor-200500263.html", "source_name": "GlobeNewswire", "published_at": "2026-05-28T20:05:00+00:00", "published_display": "28 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Closes Securities Offering", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/assembly-biosciences-closes-securities-offering-204836406.html", "source_name": "MT Newswires", "published_at": "2026-05-26T20:48:36+00:00", "published_display": "26 May 2026 20:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters\u2019 Option to Purchase Additional Shares", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/assembly-biosciences-announces-closing-offering-200500723.html", "source_name": "GlobeNewswire", "published_at": "2026-05-26T20:05:00+00:00", "published_display": "26 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences closes $115 million stock offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPdllEbzZzcHpQUUdwSU1FUmFCUk55NVlmM3RZdVhYNGhWMkNxa1ZMdi01SWNQTHRGWVI2Nm9vd0dIeGNUb0hNRHNLaEhFT0ZUSDJ1SWxYc0drN2N1Tm5UdkZSdVNUY2ZzeEl6SW11cENwQ1RFcVdpckZ3MjhMQW5HbDNoTkVvMUx5SjZhdGJTTTBvQ3pVdzBSTFhUMDJFeDJ1blZyeW1UUUlqMGtMYUUxRw?oc=5", "source_name": "Investing.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Prices $100 Million Offering", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/assembly-biosciences-prices-100-million-114037004.html", "source_name": "MT Newswires", "published_at": "2026-05-22T11:40:37+00:00", "published_display": "22 May 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/assembly-biosciences-announces-expansion-abi-110000897.html", "source_name": "GlobeNewswire", "published_at": "2026-05-22T11:00:00+00:00", "published_display": "22 May 2026 11:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPN0hGZTd5TkhJLXRGaW9wZEFXUTkxMHpVZDEyVUVwdHVIWWlreGJyUzJzUlJzcTZZR04wY3FzWEVfNFZleTJpSmpUOEFtRnVOdWdtVWFuYXZ5cFVmdVNMcGRhRXpCWjFFbDk2VnRKT1RWV0JCbWdrSkFhMEs1VF9qTHBqUkFST3BuRlhQNENyTkZKemM4QmFvU3RTZjBkWmdfOXJCNHJPOUhNdDNRVVc4VWF3VjlIUTRYMTVXaXgxSTMzc2ZZTXp3QU5xdWJQTHdCQjJ1MnY0dXFpLXhoTktjOUpiTW9iVFE?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences prices $100 million stock offering at $26.50", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNUXRrZDcyZVhKcjNoTXlEYzVFSjRVVXo3SHJZalJLeWZCLXNfQ3VnVmFzZXN2Y3NBaXkzZVNEY3d5ZXpQd2xCWklHSTdYTkNzTnJ2bFJ1VjlHdk0yTjB2UnBzT0RNMGZ1bWU3ZC1SRk1NS0VMNm9yVUVvdElLcTFXR0JmQW1DX1JIWUszS2FDMWZ3d1A5Z2l5SXp4WnJpdzdOTGJNaW1DQnVfWDlaSC1nbVFlS3NQcDNtZmQ0?oc=5", "source_name": "Investing.com", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcjZqdzdBcURDdWxCZUtoU1dTaHYtVUFRdlo1a3ZGZGY3a1dBX2x2UVE3Y1hoX1duLXhGU2p0UXU2eTctNng5eFJ5c1M0bHBNQ0VmZTFZanhYU21yTVo0UTQtVENveVV1aWdpc3luUlgza3AyUEI2OGx4aEhXc0pBTHpWUThSYXI1S3RTS21lQ21vWjd6MGY4ZDRwVWlEakc3SmFKN09aM0Rlb2pFT3BNNW1GTExnSElFb2NqR3JhX0J3MlptQy1mMk9IOTZtdS1HU25fLU9aOU9XZi1PRDlkZVI2cnhackHSAewBQVVfeXFMTlc2N3pIUkxDd1NtTlVRMEdac1JNSDF3cUNidkZrTElQREZaUTZjZmFHdUVWYW8wcDg1LThGbnlPb0VQUFI4ZXdjSXR6Ym5DREM1X2lyQUtYTzF3XzBBTGRGcEZQQ3FjLWxCQ0locVM2dGZJR1kxYmlBQXdsbFhfbFFISS1wSUkxQmp4U2d2Z3JHbXRPMUpnajBydTRmNnQzZmF5eEdzOVFRNUdDNVV0aDJQNERCaXN3ZGo1UUc1ZGkwOFYzcDgxS1ltZllDeTFxNFIxT3FyOUxLMFNrLUhtOFNFV0xMYkM5TlpWMzk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Assembly Biosciences Touts HSV, Hepatitis D Catalysts at BofA Conference", "summary": "", "url": "https://finance.yahoo.com/m/91c40cdb-2fcf-3923-97fd-698a276b8f12/assembly-biosciences-touts.html", "source_name": "MarketBeat", "published_at": "2026-05-14T11:05:48+00:00", "published_display": "14 May 2026 11:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "These Analysts Just Made A Huge Downgrade To Their Assembly Biosciences, Inc. (NASDAQ:ASMB) EPS Forecasts", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Hopeful That Assembly Biosciences (NASDAQ:ASMB) Will Use Its Cash Wisely", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNaVp1dVdTNHdJUzFSdnozTC1HUDFEMW80eG9DMWRqbFJmWlVzakwybU5FQzBMdFZNQ2UwSTJyYXdsRmVwM1RXcWtObkJ3XzFOMVhrWTVraHloMEJmNUNfeGJ2eE56QmtGR1l4RU9sSk5TM0NCNlNCTFZHZV9IR0gtZDY3eUdHc2ZTanZ5akdjVHJFM19rOTdwV1J4UVRaY0g1VzVzMlNCVFg?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Assembly Biosciences (ASMB) Reports Q1 Loss, Misses Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxORDlFQ0plbGFBeEhqbF9hTHU4ZXFERVAzMnBZeTBGdWIycHYybWQyckJRNElzZ21IQ0g1eWk4bDBtRXJlWmRqY3owaE5keFBDUmQ5aVVqMWlVdlBXUGlyNUdKa2FwU1lwcE94ZzJjSXhCSWN1bW0tazFlbWRZTjAwbGV0NEZ3TEpub0tKanBJZFl5cGpaX19telNuQm1fNVd5aUx0RmhNbHM?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Assembly Biosciences: 'Buy' On HPI Program Opt-In And HDV Candidate Development (ASMB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOU2VmTzd3U3BDeENldDhDbzkyYzdDVGgzaTllaVQxWWlSdmxHZFJzcTgzU3EwQU8zeHFyblE0VUV3UFZ2ZDkzSG5zMHp3VkJkalkxX2pQcy0xa1FtaVd6cUNPUW1CX0t0RTRvR3NOOVFqd3BNY0N1cU1aOC1iZXlWdjZ2eGlONFFoNXNaU3VfYWIyTzVWeDItSTBUUElLZGQ0bG85TS0yZVEydEdrbEFUakhXREpHdGxl?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) Quarterly Profit Of US$22.1 Million Tests Bearish Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQQjZXV0RMVU1BX20taktBaWVEWWswWGZxVTVGV1RJd21ySGFVd195cnRqSDF4Z3NoNXFzbDI4ZjA1YW5BZU1hYUlnRlZ6SW53TWRlR29iaEtoMFFfcGRYUEVldXFTS1M3MUtpcjZ1TGlVVEVOdkRkb0sxMk1qSXJJQm9hei1vd0VxNHN4Y2d1SS13b0szeWstTVpRZnF0T3dVa2o2RThIeldGZw?oc=5", "source_name": "Market source", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Some Confidence Is Lacking In Assembly Biosciences, Inc. (NASDAQ:ASMB) As Shares Slide 27%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-22T08:00:00+00:00", "published_display": "22 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences exercises option to license Assembly Biosciences Helicase-Primase Inhibitor programs for...", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwJBVV95cUxQUlNGRHc0UGJwVHVvQXNMeXBneHlKQVB0Q0E0bXRZZldJLWYwRjlwVlN2V213M1czYXpGVVNDck9KZERITldzTkNvLWZEYzAycFdCVElYVDhuaWtZYjFBTlNFWFlENXpvQTA4QkdFaVhab1FjVkFzNmFJalc5c0NCN1JjUi1MMzZ5VmYwUlVEbGJ4MEp4bGd2WlNRODR4T19PcEJvN1Vjd09hWHVFbjNDZzVHS1dXTHFuZEQ1Q2ItOGVMdVJWejdvZFpYMW02ZWJNM0w3ZTRQbHAzOW9nSjBtUnkyODAzMXNQQ2tHUVVSY1pDZEpleWVaTUVjR2hHV3BXc1l2anpYeENJS0lKVnlwd1dWRdIBmAJBVV95cUxQSXhpYjZsRzFGOGRvUzZHeGllMjRYd2taSmtka1I2RDVLYkhPNVNESlNvLUpVMkhnd0xkeEI0eTQtV2ZzQXdYTFFtZ2ZRTzNqNlk2STljN0l5WnZuamtZT19EM29Bb0ZxNW5sMy1zUjRPMm1NWEp2RC1ocm14SFBtRHV4ek9YT0g5MFJGaURDU2VRY3NyNUxVbldNdWMzN3gzcGpTTlJtU2IxNndMaEFjLUEzTENRamN3YU9JQ1IwVDE1NlZlVWpWRkppS2tYcXJTZk1MaXhYcU5mOWdIYUZRV0g2M1UzSTlaa0REV1JKUnNQWkxGdGpjTHU3QmtCTzdmM0hTQ19yRlh6SV9Da1pkdGtKX2hNYmdG?oc=5", "source_name": "Medical Dialogues", "published_at": "2025-12-28T08:00:00+00:00", "published_display": "28 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Stock Jumps After Wall Street Says Gilead Opt-In \u2018Significantly De-Risks\u2019 Genital Herpes Programs", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwJBVV95cUxQV1Y1RHJiWlF4ZWtoYXZiTFdOWDNOVW5zNlRSaE1aZGZhR3hDbWk3WEJIVkoxdG8xYWdGSURtZkRfODZiNGVQb2Nka0JUWm9RRERaY1dEdFl4TUNEQjJKRDk4cTFtT2M4TXpwamhLVXFJbmthNjBQNmo3dm5QZXZycFBMRF90b0l3OWhOUXlYeE5jbFNUQWJubGdYbkM0d05Hd0VDSXlEQW50US0tUHFIVml4bmFiQ1M0X2lKOVhlX1lUNWpyb0haeUx2TkFXY2lpUFYzd2FrNXMtRmNGT1lxLXdQUEVNR2dxM3AyRlRicFlvRzhBcVM4RlBqcFlBZ3dlMHM1ZThXaExwTlk?oc=5", "source_name": "Stocktwits", "published_at": "2025-12-22T08:00:00+00:00", "published_display": "22 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences stock rises after promising HSV drug results", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOd1RXMUlGMF90TmQtendnZnNjRWNiOUVka0h2Y0UxdmRwbjBVVVJjUVhZRy15TkZwWmdTYUpURzgzQnVFQ1NYSkR5M1BOdUJDd2RKcG4wRWVpQmxIaUxURXBmal9aTnRKbTluLWo5cGdwZXVPWWJsajVvTzNrUnA5RTdQdHRMSXkyZDRxZ3hJTGJCandvVURGR092bjFqVlVJX1BkODlHaWp0Tlh4YjY4UVJFaXZyR2FUYjhsY2R6SVdxMk5fcGc?oc=5", "source_name": "Investing.com", "published_at": "2025-12-08T08:00:00+00:00", "published_display": "08 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Companies Like Assembly Biosciences (NASDAQ:ASMB) Can Afford To Invest In Growth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-02T08:00:00+00:00", "published_display": "02 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Enterprise value to EBIT forward of Assembly Biosciences, Inc. \u2013 NASDAQ:ASMB", "summary": "The article provides a financial overview of Assembly Biosciences, Inc. (NASDAQ: ASMB), focusing on its enterprise value to EBIT forward. It primarily presents the title and basic identification of the company within a financial data platform. The content primarily consists of na", "url": "https://www.tradingview.com/symbols/NASDAQ-ASMB/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-14T22:42:31", "published_display": "14 Jul 2026 22:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Avoiding Lag: Real-Time Signals in (ASMB) Movement", "summary": "This article provides an AI-generated analysis of Assembly Biosciences Inc. (NASDAQ: ASMB), noting a near-term neutral sentiment amidst mid and long-term strength. It highlights a significant 65.7:1 risk-reward short setup and outlines three institutional trading strategies: a lo", "url": "https://news.stocktradersdaily.com/news_release/10/Avoiding_Lag:_Real-Time_Signals_in_ASMB_Movement_071126061602_1783808162.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-11T18:40:18", "published_display": "11 Jul 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Assembly Biosciences, Inc. \u2013 HAM:V7B", "summary": "This article focuses on the enterprise value to EBIT forward ratio for Assembly Biosciences, Inc. (HAM:V7B) on the Hamburg Stock Exchange. It appears to be a financial data page from TradingView, providing an overview of the company's financials without offering specific numerica", "url": "https://www.tradingview.com/symbols/HAM-V7B/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-10T05:09:47", "published_display": "10 Jul 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Assembly Biosciences, Inc. \u2013 FWB:V7B", "summary": "This article displays information regarding the price to earnings forward of Assembly Biosciences, Inc. (FWB:V7B) on the Frankfurt Stock Exchange. It notes that the market is currently closed with no trades. The article is part of TradingView's financial data offerings.", "url": "https://www.tradingview.com/symbols/FWB-V7B/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-09T18:42:16", "published_display": "09 Jul 2026 18:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Assembly Biosciences, Inc. \u2013 NASDAQ:ASMB", "summary": "This article provides a brief snapshot of the Enterprise Value to Revenue (Forward) for Assembly Biosciences, Inc. (NASDAQ: ASMB) as presented on TradingView. It highlights key financial metrics and navigational elements related to the company's profile on the platform. The conte", "url": "https://www.tradingview.com/symbols/NASDAQ-ASMB/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T11:10:14", "published_display": "08 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) Holds Steady Near Resistance Zone - Overbought Signal Alerts", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQOUJDMTdZNTI0amVJSUlMZU1WVXdiNjlZM19ZVTlHOVc5UzNnN3RlRmdUcUhlSDhsZExmNUo4eVp6T0pxRGZ3S3U5Sll6d2ZZZXZla19hVHYxdnZ6azZCOF9yRU8zZnJFOHRDaXNFemo1cl83SjJZbUR6bG5YcVNYU3hveDBDXzE4b3hiekVILXk3OEt5OTJoSDBtTFVUcVhzMXVr?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-07T18:36:07+00:00", "published_display": "07 Jul 2026 18:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Assembly Biosciences, Inc. \u2013 NASDAQ:ASMB", "summary": "This article focuses on the enterprise value to EBITDA forward metric for Assembly Biosciences, Inc. (NASDAQ: ASMB). It indicates that the company's financial data is available for review, likely on the TradingView platform. The content primarily serves as a placeholder for detai", "url": "https://www.tradingview.com/symbols/NASDAQ-ASMB/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T06:39:31", "published_display": "07 Jul 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Assembly Biosciences, Inc. \u2013 NASDAQ:ASMB", "summary": "This article provides a financial snapshot for Assembly Biosciences, Inc. (NASDAQ: ASMB), focusing on its price to book forward metric. It appears to be a stub or an incomplete data entry from TradingView, lacking detailed financial figures but highlighting the company within the", "url": "https://www.tradingview.com/symbols/NASDAQ-ASMB/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T21:11:32", "published_display": "05 Jul 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASMB - Assembly Biosciences Inc Options", "summary": "This article provides a detailed financial overview of Assembly Biosciences Inc. (ASMB), including its current stock performance, key financial metrics, analyst ratings, and insider transaction data. It highlights the company's valuation, profitability, growth rates, and market i", "url": "https://finviz.com/stock?t=ASMB&ta=1&p=m&ty=oc&b=2&ov=chain_strike&s=35", "source_name": "Finviz", "published_at": "2026-07-02T22:09:28", "published_display": "02 Jul 2026 22:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Discipline and Rules-Based Execution in ASMB Response", "summary": "This article provides an in-depth analysis of Assembly Biosciences Inc. (NASDAQ: ASMB), highlighting strong sentiment across all horizons and identifying a mid-channel oscillation pattern. It presents three AI-generated institutional trading strategies\u2014Position Trading, Momentum ", "url": "https://news.stocktradersdaily.com/news_release/12/Discipline_and_Rules-Based_Execution_in_ASMB_Response_063026050801_1782853681.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-30T17:08:00", "published_display": "30 Jun 2026 17:08", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 2500 Index", "summary": "Assembly Biosciences, Inc. (NasdaqGS: ASMB), a biotechnology company focused on developing therapies for serious viral diseases, has been added to the Russell 2500 Index. This inclusion is one of several recent adjustments for the company across various Russell indices, including", "url": "https://www.marketscreener.com/news/assembly-biosciences-inc-nasdaqgs-asmb-added-to-russell-2500-index-ce7f5fdfd188f523", "source_name": "marketscreener.com", "published_at": "2026-06-29T13:11:46", "published_display": "29 Jun 2026 13:11", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 3000E Value Benchmark", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNNUw5UkIzSjVhczhpajVqb1NRV0FqMk9LemRzRGpJbnB2ckMtUjltV1ItTDBLdnFDeG93S2Zub2tfQW84cWN4WkNncGVGMG05eXhCRFZSZDZCbGkxOWZraXhYNFlvZDdzVEU2VGxOSFY3RnhEbjdTQTFVSmN6VW8xaU1yOXlNTTk1Mm1zR2tLc1lBYWtuZ2RVY2JRMkZuRm01d0hPOHhVS2VMQzhJdFpiSExaOGxReDJZQ2ZNdXNwNmFhanY1eTZScVR3?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences, Inc. Actuals & Estimates (NASDAQ:ASMB)", "summary": "This article provides an overview of Assembly Biosciences, Inc. (NASDAQ: ASMB) stock, including its current price, market capitalization, and historical performance. It details analyst forecasts, past earnings reports, and upcoming financial dates, such as the next earnings relea", "url": "https://www.tradingview.com/symbols/NASDAQ-ASMB/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T05:40:22", "published_display": "26 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASMB Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Assembly Biosciences, Inc. (ASMB) stock, including analyst price targets, historical performance data, and financial metrics. Four analysts have provided 1-year price forecasts, with estimates ranging from $43.00 to $62.00. The company's stock", "url": "https://www.tradingview.com/symbols/NASDAQ-ASMB/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T20:09:46", "published_display": "25 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Inc (ASMB) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Assembly Biosciences Inc (ASMB), detailing its current price momentum score, support and resistance levels. It includes a review of various technical indicators like MACD, RSI, and moving averages, offering \"Sell,\" \"Neutral,\" or \"Buy\"", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-asmb/technical", "source_name": "TradingKey", "published_at": "2026-06-24T18:40:22", "published_display": "24 Jun 2026 18:40", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (Nasdaq:ASMB) - Stock Analysis", "summary": "This report provides a comprehensive stock analysis of Assembly Biosciences (ASMB), detailing its financial performance, future growth prospects, past performance, and risk factors. It highlights that ASMB is trading significantly below its estimated fair value with promising ear", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-asmb/assembly-biosciences", "source_name": "Simply Wall Street", "published_at": "2026-06-23T07:09:11", "published_display": "23 Jun 2026 07:09", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Inc (ASMB) Institutional Confidence", "summary": "This article analyzes the institutional confidence in Assembly Biosciences Inc (ASMB), noting its current score of 5.00 within the Biotechnology & Medical Research industry. Institutional shareholding has increased significantly by 171.06% quarter-over-quarter, now standing at 58", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-asmb/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T16:10:18", "published_display": "18 Jun 2026 16:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) PFO sells 29 shares to cover RSU taxes", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPS2R5UGdWSmxQbjllaGtsREdHb2Qwa0ZWTUVrNjVqUjNicmxjbC1FX3U3M0RGTmVTWTVmY3FhcHN1cGs1WEJOMjJLZzBYUjdQV25NOC1fWFBKd3lla0IzN09pWFpnREpTMDRzM2o3a2dKQ3lORnVZRjVGZ0Fhcl9MSDZnc2pIbUFtenJDeTBZT0laWTZoMTE3R1c1bndQLV81dnc3YURMZlNIdjhwYjVFWVlTcENmMU04c3c?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Inc (ASMB) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Assembly Biosciences Inc (ASMB), detailing its current earnings forecast score, average price target, and analyst ratings. It highlights that the company ranks 16th in the Biotechnology & Medical Research industry with a strong buy c", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-asmb/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T04:41:07", "published_display": "18 Jun 2026 04:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Inc (ASMB) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Assembly Biosciences Inc (ASMB), listing its major shareholders and their proportions, including Gilead Sciences Inc, Farallon Capital Management, and RA Capital Management. It also breaks down shareholder types such as hedge fund", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-asmb/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T21:09:51", "published_display": "17 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Inc (ASMB) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Assembly Biosciences Inc (ASMB) focusing on its dividend and stock split history. It indicates that the company has not distributed dividends in the past five years and lists several stock merger events that occurred on February 8, 2024, with ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-asmb/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T21:09:51", "published_display": "17 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mizuho Raises Price Target on Assembly Biosciences to $45 From $40, Keeps Outperform Rating", "summary": "Mizuho has increased its price target for Assembly Biosciences (ASMB) to $45 from $40, while maintaining an \"Outperform\" rating on the stock. This adjustment comes despite a report within the same article about Unity Software's Q4 earnings, which showed higher-than-expected reven", "url": "https://www.moomoo.com/news/post/71532495/mizuho-raises-price-target-on-assembly-biosciences-to-45-from?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-06-16T03:09:51", "published_display": "16 Jun 2026 03:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead", "summary": "Assembly Biosciences highlighted its antiviral and liver disease development strategy, discussing upcoming decisions for its HSV-2 program with Gilead, the expansion of its hepatitis delta candidate into cholestatic liver diseases, and expected clinical data readouts. The company", "url": "https://www.theglobeandmail.com/investing/markets/stocks/ASMB-Q/pressreleases/2383505/assembly-biosciences-teases-gilead-hsv-2-decision-liver-disease-data-ahead/", "source_name": "The Globe and Mail", "published_at": "2026-06-09T13:09:41", "published_display": "09 Jun 2026 13:09", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences eyes Gilead HSV plan as ABI-6250 liver pipeline expands", "summary": "This article mentions Assembly Biosciences' interest in Gilead's HSV plan and the expansion of its ABI-6250 liver pipeline. No further details are provided in the given content.", "url": "https://www.msn.com/en-us/health/other/assembly-biosciences-eyes-gilead-hsv-plan-as-abi-6250-liver-pipeline-expands/ar-AA24WCUt?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-06-08T21:39:23", "published_display": "08 Jun 2026 21:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(ASMB) Movement Within Algorithmic Entry Frameworks", "summary": "This article from Stock Traders Daily analyzes Assembly Biosciences (ASMB) using AI models, identifying weak near- and mid-term sentiment but a strong long-term outlook. It provides specific algorithmic trading strategies\u2014Long Position, Momentum Breakout, and Risk Hedging Short\u2014a", "url": "https://news.stocktradersdaily.com/news_release/16/ASMB_Movement_Within_Algorithmic_Entry_Frameworks_060826024802_1780944482.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-08T14:48:00", "published_display": "08 Jun 2026 14:48", "sentiment": "negative", "sentiment_pct": 38, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) CEO receives 50,750 RSUs in equity grant", "summary": "Assembly Biosciences (ASMB) CEO and President Jason A. Okazaki received a grant of 50,750 Restricted Stock Units (RSUs) at no cash cost. This grant, approved on March 29, 2026, became issuable after stockholders approved an amendment to the company's 2018 Stock Incentive Plan on ", "url": "https://www.stocktitan.net/sec-filings/ASMB/form-4-assembly-biosciences-inc-insider-trading-activity-566a778a94de.html", "source_name": "Stock Titan", "published_at": "2026-06-06T12:10:46", "published_display": "06 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (NASDAQ: ASMB) awards 8,000 stock options to director McHutchison", "summary": "Assembly Biosciences (NASDAQ: ASMB) has granted 8,000 stock options to its director, John G. McHutchison. These options have an exercise price of $24.11 per share and are set to expire on June 4, 2036. The vesting of these options is contingent on continuous service and will occu", "url": "https://www.stocktitan.net/sec-filings/ASMB/form-4-assembly-biosciences-inc-insider-trading-activity-3f096425de2f.html", "source_name": "Stock Titan", "published_at": "2026-06-06T10:40:20", "published_display": "06 Jun 2026 10:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) CSO granted 14,000 RSUs tied to plan amendment", "summary": "Assembly Biosciences' Chief Scientific Officer, William E. Delaney IV, was granted 14,000 Restricted Stock Units (RSUs), representing 35% of his annual equity award. This grant, made at no cash cost, was contingent on stockholder approval of an amendment to the company's 2018 Sto", "url": "https://www.stocktitan.net/sec-filings/ASMB/form-4-assembly-biosciences-inc-insider-trading-activity-fb393ad3c64a.html", "source_name": "Stock Titan", "published_at": "2026-06-06T00:09:52", "published_display": "06 Jun 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (NASDAQ: ASMB) director receives 8,000 stock options grant", "summary": "Assembly Biosciences director Lisa Johnson-Pratt was granted 8,000 stock options with an exercise price of $24.11 per share, expiring on June 4, 2036. The options vest upon the earlier of June 4, 2027, or the company's 2027 annual stockholder meeting, assuming continuous service.", "url": "https://www.stocktitan.net/sec-filings/ASMB/form-4-assembly-biosciences-inc-insider-trading-activity-7bc09e80a5db.html", "source_name": "Stock Titan", "published_at": "2026-06-05T23:08:49", "published_display": "05 Jun 2026 23:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at Assembly Biosciences (ASMB) receives grant of 8,000 stock options", "summary": "Michael Houghton, a director at Assembly Biosciences (ASMB), has received a grant of 8,000 stock options. These options have an exercise price of $24.11 per share, expire on June 4, 2036, and will vest on the earlier of June 4, 2027, or the company's 2027 annual meeting of stockh", "url": "https://www.stocktitan.net/sec-filings/ASMB/form-4-assembly-biosciences-inc-insider-trading-activity-07d16cbac4d6.html", "source_name": "Stock Titan", "published_at": "2026-06-05T22:40:44", "published_display": "05 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) director receives grant of 8,000 stock options", "summary": "Assembly Biosciences (ASMB) director Susan Mahony was granted 8,000 stock options with an exercise price of $24.11 per share, expiring on June 4, 2036. The options will vest upon the earlier of June 4, 2027, or the company's 2027 annual meeting of stockholders, assuming continuou", "url": "https://www.stocktitan.net/sec-filings/ASMB/form-4-assembly-biosciences-inc-insider-trading-activity-712d89588682.html", "source_name": "Stock Titan", "published_at": "2026-06-05T22:40:44", "published_display": "05 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) CMO awarded 14,000 restricted stock units", "summary": "Assembly Biosciences' Chief Manufacturing Officer, Nicole S. White, was granted 14,000 restricted stock units (RSUs) as part of her annual equity compensation. This grant, approved on March 29, 2026, became issuable after stockholders approved an amendment to the company\u2019s 2018 S", "url": "https://www.stocktitan.net/sec-filings/ASMB/form-4-assembly-biosciences-inc-insider-trading-activity-a0a69b1f46d7.html", "source_name": "Stock Titan", "published_at": "2026-06-05T21:11:02", "published_display": "05 Jun 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Announces Upcoming Investor Conference Presentations", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/assembly-biosciences-announces-upcoming-investor-200500263.html", "source_name": "GlobeNewswire", "published_at": "2026-05-28T20:05:00+00:00", "published_display": "28 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Closes Securities Offering", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/assembly-biosciences-closes-securities-offering-204836406.html", "source_name": "MT Newswires", "published_at": "2026-05-26T20:48:36+00:00", "published_display": "26 May 2026 20:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters\u2019 Option to Purchase Additional Shares", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/assembly-biosciences-announces-closing-offering-200500723.html", "source_name": "GlobeNewswire", "published_at": "2026-05-26T20:05:00+00:00", "published_display": "26 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences closes $115 million stock offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxPdllEbzZzcHpQUUdwSU1FUmFCUk55NVlmM3RZdVhYNGhWMkNxa1ZMdi01SWNQTHRGWVI2Nm9vd0dIeGNUb0hNRHNLaEhFT0ZUSDJ1SWxYc0drN2N1Tm5UdkZSdVNUY2ZzeEl6SW11cENwQ1RFcVdpckZ3MjhMQW5HbDNoTkVvMUx5SjZhdGJTTTBvQ3pVdzBSTFhUMDJFeDJ1blZyeW1UUUlqMGtMYUUxRw?oc=5", "source_name": "Investing.com", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Prices $100 Million Offering", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/assembly-biosciences-prices-100-million-114037004.html", "source_name": "MT Newswires", "published_at": "2026-05-22T11:40:37+00:00", "published_display": "22 May 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/assembly-biosciences-announces-expansion-abi-110000897.html", "source_name": "GlobeNewswire", "published_at": "2026-05-22T11:00:00+00:00", "published_display": "22 May 2026 11:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPN0hGZTd5TkhJLXRGaW9wZEFXUTkxMHpVZDEyVUVwdHVIWWlreGJyUzJzUlJzcTZZR04wY3FzWEVfNFZleTJpSmpUOEFtRnVOdWdtVWFuYXZ5cFVmdVNMcGRhRXpCWjFFbDk2VnRKT1RWV0JCbWdrSkFhMEs1VF9qTHBqUkFST3BuRlhQNENyTkZKemM4QmFvU3RTZjBkWmdfOXJCNHJPOUhNdDNRVVc4VWF3VjlIUTRYMTVXaXgxSTMzc2ZZTXp3QU5xdWJQTHdCQjJ1MnY0dXFpLXhoTktjOUpiTW9iVFE?oc=5", "source_name": "marketscreener.com", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences prices $100 million stock offering at $26.50", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNUXRrZDcyZVhKcjNoTXlEYzVFSjRVVXo3SHJZalJLeWZCLXNfQ3VnVmFzZXN2Y3NBaXkzZVNEY3d5ZXpQd2xCWklHSTdYTkNzTnJ2bFJ1VjlHdk0yTjB2UnBzT0RNMGZ1bWU3ZC1SRk1NS0VMNm9yVUVvdElLcTFXR0JmQW1DX1JIWUszS2FDMWZ3d1A5Z2l5SXp4WnJpdzdOTGJNaW1DQnVfWDlaSC1nbVFlS3NQcDNtZmQ0?oc=5", "source_name": "Investing.com", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Touts HSV, Hepatitis D Catalysts at BofA Conference", "summary": "", "url": "https://finance.yahoo.com/m/91c40cdb-2fcf-3923-97fd-698a276b8f12/assembly-biosciences-touts.html", "source_name": "MarketBeat", "published_at": "2026-05-14T11:05:48+00:00", "published_display": "14 May 2026 11:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "These Analysts Just Made A Huge Downgrade To Their Assembly Biosciences, Inc. (NASDAQ:ASMB) EPS Forecasts", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Hopeful That Assembly Biosciences (NASDAQ:ASMB) Will Use Its Cash Wisely", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNaVp1dVdTNHdJUzFSdnozTC1HUDFEMW80eG9DMWRqbFJmWlVzakwybU5FQzBMdFZNQ2UwSTJyYXdsRmVwM1RXcWtObkJ3XzFOMVhrWTVraHloMEJmNUNfeGJ2eE56QmtGR1l4RU9sSk5TM0NCNlNCTFZHZV9IR0gtZDY3eUdHc2ZTanZ5akdjVHJFM19rOTdwV1J4UVRaY0g1VzVzMlNCVFg?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) Reports Q1 Loss, Misses Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxORDlFQ0plbGFBeEhqbF9hTHU4ZXFERVAzMnBZeTBGdWIycHYybWQyckJRNElzZ21IQ0g1eWk4bDBtRXJlWmRqY3owaE5keFBDUmQ5aVVqMWlVdlBXUGlyNUdKa2FwU1lwcE94ZzJjSXhCSWN1bW0tazFlbWRZTjAwbGV0NEZ3TEpub0tKanBJZFl5cGpaX19telNuQm1fNVd5aUx0RmhNbHM?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences: 'Buy' On HPI Program Opt-In And HDV Candidate Development (ASMB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOU2VmTzd3U3BDeENldDhDbzkyYzdDVGgzaTllaVQxWWlSdmxHZFJzcTgzU3EwQU8zeHFyblE0VUV3UFZ2ZDkzSG5zMHp3VkJkalkxX2pQcy0xa1FtaVd6cUNPUW1CX0t0RTRvR3NOOVFqd3BNY0N1cU1aOC1iZXlWdjZ2eGlONFFoNXNaU3VfYWIyTzVWeDItSTBUUElLZGQ0bG85TS0yZVEydEdrbEFUakhXREpHdGxl?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) Quarterly Profit Of US$22.1 Million Tests Bearish Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQQjZXV0RMVU1BX20taktBaWVEWWswWGZxVTVGV1RJd21ySGFVd195cnRqSDF4Z3NoNXFzbDI4ZjA1YW5BZU1hYUlnRlZ6SW53TWRlR29iaEtoMFFfcGRYUEVldXFTS1M3MUtpcjZ1TGlVVEVOdkRkb0sxMk1qSXJJQm9hei1vd0VxNHN4Y2d1SS13b0szeWstTVpRZnF0T3dVa2o2RThIeldGZw?oc=5", "source_name": "Market source", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Some Confidence Is Lacking In Assembly Biosciences, Inc. (NASDAQ:ASMB) As Shares Slide 27%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxQZU9SZXhRUUNaMGFBbzVsQmVMZm1ZV1NqNmszRG1WWHFEMENtYmFWZ0ZycUtJUWhzb2FRY2p2b3ZwSlplUjQ3UVRDckVOSUdSUmhPM1gteVE2WXdTN19wY0ZxWDZ6RmRQeFM3djdtdXowR2Z6Y09FT1NVRkJHWXBVbFpRN2YzTjVHUVVPLVBwckZpQjNkbW9WX3FLdjFBaEs1VnFaZ29TSmJWUlFQbW94N3BRUS1mLUc3RzBmbjBMVU93bGd2dWt2MUotX20yUFFNaFNoTlllYjdlLWV4bXdoN1JXZ0w4YmtfdGfSAe8BQVVfeXFMT2xlWUdmSlFxeHd4OHVmT2lTVWROZW5SRE1MZVdObFhOQXZpMG5OYTZUa29GNVFEMk9xUkQtVE1HQjVEeEdWMzRGLXRhOTR3UWNpMmxSb2s3ZHdydXp2WFZuTC12OUxCQnQtLVhUUHc5aGhveExrTVNVRGZFaDVpSmRKd1RkUGNQcV91NXB3QTZhRG1GMUhQcER5cWE4d1ItQ0tTeVhBVFpqS2FBVi1nbC1hNDM0RlJ2MjJQZktPOVdiUGc0MHZGSGEzUmNrdlgtRUtUX2hXZm1hM1E1a3ZiOVFZYnBCMGhqWl9DX1lyaVE?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-22T08:00:00+00:00", "published_display": "22 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences exercises option to license Assembly Biosciences Helicase-Primase Inhibitor programs for...", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Medical Dialogues", "published_at": "2025-12-28T08:00:00+00:00", "published_display": "28 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences Stock Jumps After Wall Street Says Gilead Opt-In \u2018Significantly De-Risks\u2019 Genital Herpes Programs", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwJBVV95cUxQV1Y1RHJiWlF4ZWtoYXZiTFdOWDNOVW5zNlRSaE1aZGZhR3hDbWk3WEJIVkoxdG8xYWdGSURtZkRfODZiNGVQb2Nka0JUWm9RRERaY1dEdFl4TUNEQjJKRDk4cTFtT2M4TXpwamhLVXFJbmthNjBQNmo3dm5QZXZycFBMRF90b0l3OWhOUXlYeE5jbFNUQWJubGdYbkM0d05Hd0VDSXlEQW50US0tUHFIVml4bmFiQ1M0X2lKOVhlX1lUNWpyb0haeUx2TkFXY2lpUFYzd2FrNXMtRmNGT1lxLXdQUEVNR2dxM3AyRlRicFlvRzhBcVM4RlBqcFlBZ3dlMHM1ZThXaExwTlk?oc=5", "source_name": "Stocktwits", "published_at": "2025-12-22T08:00:00+00:00", "published_display": "22 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assembly Biosciences stock rises after promising HSV drug results", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOd1RXMUlGMF90TmQtendnZnNjRWNiOUVka0h2Y0UxdmRwbjBVVVJjUVhZRy15TkZwWmdTYUpURzgzQnVFQ1NYSkR5M1BOdUJDd2RKcG4wRWVpQmxIaUxURXBmal9aTnRKbTluLWo5cGdwZXVPWWJsajVvTzNrUnA5RTdQdHRMSXkyZDRxZ3hJTGJCandvVURGR092bjFqVlVJX1BkODlHaWp0Tlh4YjY4UVJFaXZyR2FUYjhsY2R6SVdxMk5fcGc?oc=5", "source_name": "Investing.com", "published_at": "2025-12-08T08:00:00+00:00", "published_display": "08 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Companies Like Assembly Biosciences (NASDAQ:ASMB) Can Afford To Invest In Growth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-02T08:00:00+00:00", "published_display": "02 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 101, "total_relevant": 62, "sentiment_summary": {"positive": 12, "negative": 6, "neutral": 44, "score": 52, "total": 62, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 21.05, "count": 37}, {"event": "earnings", "label": "Earnings", "weight": 8.25, "count": 17}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 12, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 27.4, "latest_week": "2026-07-10", "one_week_move": -1.2, "four_week_move": 19.3, "twelve_week_move": -6.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.362363, "market_dynamics_buy_signal": false, "relative_strength": -16.206916, "fair_value_gap": 50.5, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 48.7608, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.2% over one week, +19.3% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 9}, {"label": "TradingView", "count": 8}, {"label": "Stock Titan", "count": 8}, {"label": "simplywall.st", "count": 6}, {"label": "TradingKey", "count": 5}, {"label": "Stock Traders Daily", "count": 3}, {"label": "marketscreener.com", "count": 3}, {"label": "GlobeNewswire", "count": 3}], "tiers": [{"label": "Direct company coverage", "count": 54}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 37}, {"label": "Earnings", "count": 17}, {"label": "Analyst action", "count": 3}, {"label": "Balance sheet", "count": 2}, {"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "54", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.2% over one week, +19.3% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Enterprise value to EBIT forward of Assembly Biosciences, Inc. \u2013 NASDAQ:ASMB"}], "updated_at": "2026-07-18T05:26:34.898197+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}